The Nimbelle® Medical Systems team has extensive experience in medical device entrepreneurship and a profound understanding of the gains and opportunities from a dedicated TIVA workstation, accumulated since the 1990s, and has condensed this knowledge into a groundbreaking complete perioperative anesthesia system for inpatient as well as outpatient surgery.
Nimbelle® Medical Systems plans to evolve into a multinational life science group to supply the global anesthesia market with TIVA-optimized devices, generic intravenous anesthesia pharmaceuticals and proprietary disposables, contributing to an even faster shift to an anesthetic technique with four orders of magnitude smaller environmental impact and higher level of patient satisfaction.
Nimbelle® Medical Systems is currently in a funding round to build a life science group and develop the production versions of its products for global market launch. The company is seeking professional investors with a proven track record in medical device and pharmaceutical startups, focusing on high-conviction, long-term growth potential.
